To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

No significant difference in the incidence of VTE between IV TXA and control in orthopaedic surgery

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2019

No significant difference in the incidence of VTE between IV TXA and control in orthopaedic surgery

Vol: 8| Issue: 2| Number:10| ISSN#: 2564-2537
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

Safety of intravenous tranexamic acid in patients undergoing major orthopaedic surgery: a meta-analysis of randomised controlled trials

Blood Transfus. 2018 Jan;16(1):36-43

Contributing Authors:
M Franchini C Mengoli M Marietta G Marano S Vaglio S Pupella PM Mannucci GM Liumbruno

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

73 randomized controlled trials were included in this meta-analysis investigating the incidence of venous thromboembolic complications between patients administered intravenous tranexamic acid and patients who were not administered TXA. Meta-analysis demonstrated no significant difference between IV TXA groups and control groups in the incidence of VTE complications, which were estimated at 2.1% a...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue